Adalimumab Biosimilar May Reduce Antibody Response After COVID-19 Vaccine

Retrieved on: 2024-02-06 23:11:16

Tags for this article:

Immunology

Biotechnology

Monoclonal antibodies

Disease-modifying antirheumatic drug

Click the tags to see associated articles and topics

Adalimumab Biosimilar May Reduce Antibody Response After COVID-19 Vaccine. View article details on HISWAI: https://www.hcplive.com/view/adalimumab-biosimilar-reduce-antibody-response-covid-19-vaccine

Excerpt

Vaccination against COVID-19 is recommended for patients with autoimmune diseases, as this population is at increased risk of developing severe ...

Article found on: www.hcplive.com

View Original Article